[Antitumor effector cells in recombinant IL-2 activated tumor infiltrating lymphocytes from human solid cancers].

Abstract

Tumor infiltrating lymphocytes (TIL) isolated from 46 human solid cancers, including 24 renal cell carcinoma (RCC), 15 cancers of digestive organs and 7 other malignancies, were cultured with 1000 units/ml of recombinant interleukin-2 (rIL-2). Induction of activated TIL was achieved in 41 cases (89.1%). Their antitumor characteristics and cell surface… (More)

Topics

  • Presentations referencing similar topics